Edwards Lifesciences Company Insiders

EW Stock  USD 76.79  0.23  0.30%   
Slightly above 83 percent of Edwards Lifesciences' insiders are selling. The analysis of insiders' sentiment of trading Edwards Lifesciences Corp stock suggests that a fairly large number of insiders are terrified at this time. Edwards Lifesciences employs about 15.8 K people. The company is managed by 32 executives with a total tenure of roughly 181 years, averaging almost 5.0 years of service per executive, having 493.75 employees per reported executive.
Michael Mussallem  Chairman
Chairman of the Board, Chief Executive Officer
Larry Wood  President
Corporate Vice President - Transcatheter Aortic Valve Replacement

Insider Sentiment 17

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-06-16Larry L WoodDisposed 8950 @ 75.23View
2025-06-02Donald E Bobo JrDisposed 2570 @ 77.4View
2025-05-22Daveen ChopraDisposed 1500 @ 75.08View
2025-05-09Scott B UllemDisposed 11250 @ 74.4View
2025-05-07Wayne MarkowitzDisposed 268 @ 75.08View
2025-05-05Bernard J ZovighianDisposed 5980 @ 74.91View
2025-04-21Bruce WestermanDisposed @ 69.23
2025-04-14Donald E Bobo JrDisposed 9500 @ 69.81View
2025-04-08Robert Bresnahan, Jr.Acquired @ 67.04
2025-04-07Jefferson ShreveAcquired @ 69
2025-03-26Scott B UllemDisposed 11250 @ 70.87View
2025-03-13Donald E Bobo JrDisposed 9500 @ 67.96View
2025-03-10Bernard J ZovighianDisposed 6164 @ 69.51View
2025-03-03Bruce WestermanAcquired @ 71.37
2025-02-28Scott B UllemDisposed 11250 @ 70.78View
2025-02-14Steven R LorangerDisposed 5739 @ 76.42View
2025-02-13Donald E Bobo JrDisposed 6500 @ 75.75View
Monitoring Edwards Lifesciences' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.

Acquired vs Disposed

Filed vs Not Filed

Insider sentiment refers to the collective sentiment or feeling of Edwards Lifesciences' insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Edwards Lifesciences Corp. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Edwards Lifesciences' stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

Edwards Lifesciences Management Team Effectiveness

The company has Return on Asset (ROA) of 0.0842 % which means that for every $100 of assets, it generated a profit of $0.0842. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.1651 %, which means that it produced $0.1651 on every 100 dollars invested by current stockholders. Edwards Lifesciences' management efficiency ratios could be used to measure how well Edwards Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities. Total Assets is likely to climb to about 13.7 B in 2025. Non Current Assets Total is likely to climb to about 7.1 B in 2025
Net Income Applicable To Common Shares is likely to climb to about 1.8 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 548 M in 2025.

Edwards Lifesciences Workforce Comparison

Edwards Lifesciences Corp is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 87,317. Edwards Lifesciences retains roughly 15,800 in number of employees claiming about 18% of equities under Health Care industry.
The company has Net Profit Margin (PM) of 0.76 %, which suggests that even a small decline in it sales will erase profits and may result in a net loss, or a negative profit margin. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.29 %, which signifies that for every $100 of sales, it has a net operating income of $0.29.

Edwards Lifesciences Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Edwards Lifesciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Edwards Lifesciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Edwards Lifesciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Edwards Lifesciences Notable Stakeholders

An Edwards Lifesciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Edwards Lifesciences often face trade-offs trying to please all of them. Edwards Lifesciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Edwards Lifesciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Michael MussallemChairman of the Board, Chief Executive OfficerProfile
Larry WoodCorporate Vice President - Transcatheter Aortic Valve ReplacementProfile
Catherine SzymanCorporate Vice President - Critical CareProfile
Scott UllemChief Financial Officer, Corporate Vice PresidentProfile
Huimin WangCorporate Vice President - Japan, Asia and PacificProfile
JeanLuc LemercierCorporate Vice President - EMEA (Europe, Middle East and Africa)Profile
Bernard ZovighianCorporate Vice President -Surgical Heart Valve TherapyProfile
Donald BoboCorporate Vice President - Strategy and Corporate DevelopmentProfile
Paul LaVioletteIndependent DirectorProfile
Leslie HeiszIndependent DirectorProfile
Steven LorangerIndependent DirectorProfile
Kieran GallahueIndependent DirectorProfile
Nicholas ValerianiIndependent DirectorProfile
Angela FuenteDirector EngineeringProfile
Martha MarshLead Independent DirectorProfile
William LinkIndependent DirectorProfile
Ramona SequeiraIndependent DirectorProfile
Mark PetersonCorporate CounselProfile
Arnold PinkstonCorporate CounselProfile
Arnold JDCorporate CounselProfile
Heisz StoneIndependent DirectorProfile
Mark WilterdingVice RelationsProfile
Annette BrulsCanada, EMEAProfile
MD FACCCorporate OfficerProfile
Daveen ChopraCorporate Vice President - Surgical Structural HeartProfile
Christine McCauleyCorporate ResourcesProfile
Gary SorsherSenior ComplianceProfile
Daniel LippisGreater JapanProfile
Todd BrintonCo OfficerProfile
Dirksen LehmanCorporate AffairsProfile
Finn HaleyVice DevelopmentProfile
Andrew DahlSenior OfficerProfile

About Edwards Lifesciences Management Performance

The success or failure of an entity such as Edwards Lifesciences Corp often depends on how effective the management is. Edwards Lifesciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Edwards management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Edwards management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 15700 people.
Please note, the imprecision that can be found in Edwards Lifesciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Edwards Lifesciences Corp. Check Edwards Lifesciences' Beneish M Score to see the likelihood of Edwards Lifesciences' management manipulating its earnings.

Edwards Lifesciences Workforce Analysis

Traditionally, organizations such as Edwards Lifesciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Edwards Lifesciences within its industry.

Edwards Lifesciences Manpower Efficiency

Return on Edwards Lifesciences Manpower

Revenue Per Employee344.3K
Revenue Per Executive170M
Net Income Per Employee263.9K
Net Income Per Executive130.3M
Working Capital Per Employee302.5K
Working Capital Per Executive149.4M

Additional Tools for Edwards Stock Analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.